SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CNMD - Any Info Appreciated
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  
To: Rafael Kronzon who wrote ()7/18/1996 2:09:00 PM
From: Robert Horwitz   of 29
 
Conmed is a very stable company
that has historically grown by acquisitions. A recent acquisition of
an ECG patch comapny called NMD, which was purchased for $32 mil
didnot not meet revenue expectations. The market punished the stock to
the tune of a reduction in market value of $ 150 mil. It seems to be
an overreaction on the part of investors. I think it is a cheap stock
that should return its historic growth of 20% plus on the bottom line
in the next fiscal year. Analyst estimates are $ 1.10 this year, $1.40
next, a cheap stock.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFileNext 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News